FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:769-772 March 23, 1989 Number 12 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Opinions differ concerning the efficacy of prophylaxis against neonatal chlamydial and gonococcal conjunctivitis. From January 1986 through June 1988, we gave all infants born at Kings County Hospital Medical Center one of three prophylactic agents -- silver nitrate drops, erythromycin ophthalmic ointment, or tetracycline ophthalmic ointment. The treatments were rotated monthly. Gonococcal ophthalmia occurred in 8 of the 12,431 infants born during the study (0.06 percent), 1 in the silver nitrate group, 4 in the erythromycin group, and 3 in the tetracycline group (P not significant). Seven of these infants were born to women who had received no prenatal care. From September 1985 through December 1987, we screened 4357 pregnant women for cervical chlamydial infection, of whom 341 (8 percent) had positive cultures. Of their offspring, 230 were evaluated for neonatal chlamydial conjunctivitis; the incidence was 20 percent in the silver nitrate group, 14 percent in the erythromycin group, and 11 percent in the tetracycline group (P not significant). We conclude that neonatal ocular prophylaxis with either erythromycin or tetracycline ophthalmic ointment does not significantly reduce the incidence of chlamydial conjunctivitis in the offspring of mothers with chlamydial infection as compared with silver nitrate, and that better management of maternal chlamydial infection is therefore required. We also conclude that there is a small but appreciable incidence of neonatal gonococcal ophthalmia that could be prevented by better prenatal screening and treatment of maternal gonococcal infection.

Source Information

Department of Pediatrics, State University of New York Health Science Center, Brooklyn 11203.

This article has been cited by other articles:

• Ramirez-Ortiz, M. A, Rodriguez-Almaraz, M., Ochoa-DiazLopez, H., Diaz-Prieto, P., Rodriguez-Suarez, R. S (2007). Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico. Br. J. Ophthalmol. 91: 1430-1434 [Abstract] [Full Text]  
• Bhutta, Z. A., Darmstadt, G. L., Hasan, B. S., Haws, R. A. (2005). Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence. Pediatrics 115: 519-617 [Abstract] [Full Text]  
• Moyer, V. A., Butler, M. (2004). Gaps in the Evidence for Well-Child Care: A Challenge to Our Profession. Pediatrics 114: 1511-1521 [Abstract] [Full Text]  
• Rosenman, M. B., Mahon, B. E., Downs, S. M., Kleiman, M. B. (2003). Oral Erythromycin Prophylaxis vs Watchful Waiting in Caring for Newborns Exposed to Chlamydia trachomatis. Arch Pediatr Adolesc Med 157: 565-571 [Abstract] [Full Text]  
• Block, S. L., Hedrick, J., Tyler, R., Smith, A., Findlay, R., Keegan, E., Stroman, D. W. (2000). Increasing Bacterial Resistance in Pediatric Acute Conjunctivitis (1997-1998). Antimicrob. Agents Chemother. 44: 1650-1654 [Abstract] [Full Text]  
• Darville, T. (1998). Chlamydia. Pediatr. Rev. 19: 85-91 [Full Text]  
• Isenberg, S. J., Apt, L., Wood, M. (1995). A Controlled Trial of Povidone-Iodine as Prophylaxis against Ophthalmia Neonatorum. NEJM 332: 562-566 [Abstract] [Full Text]  
• Zanoni, D., Isenberg, S. J., Apt, L. (1992). A Comparison of Silver Nitrate with Erythromycin for Prophylaxis Against Ophthalmia Neonatorum. CLIN PEDIATR 31: 295-298 [Abstract]  
• (1989). FRUSTRATION IN CONTROLLING NEONATAL CHLAMYDIAL AND GONOCOCCAL INFECTIONS. JWatch General 1989: 4-4 [Full Text]